IDEAS home Printed from https://ideas.repec.org/a/eee/socmed/v200y2018icp182-189.html
   My bibliography  Save this article

Rethinking health sector procurement as developmental linkages in East Africa

Author

Listed:
  • Mackintosh, Maureen
  • Tibandebage, Paula
  • Karimi Njeru, Mercy
  • Kariuki Kungu, Joan
  • Israel, Caroline
  • Mujinja, Phares G.M.

Abstract

Health care forms a large economic sector in all countries, and procurement of medicines and other essential commodities necessarily creates economic linkages between a country's health sector and local and international industrial development. These procurement processes may be positive or negative in their effects on populations' access to appropriate treatment and on local industrial development, yet procurement in low and middle income countries (LMICs) remains under-studied: generally analysed, when addressed at all, as a public sector technical and organisational challenge rather than a social and economic element of health system governance shaping its links to the wider economy. This article uses fieldwork in Tanzania and Kenya in 2012–15 to analyse procurement of essential medicines and supplies as a governance process for the health system and its industrial links, drawing on aspects of global value chain theory. We describe procurement work processes as experienced by front line staff in public, faith-based and private sectors, linking these experiences to wholesale funding sources and purchasing practices, and examining their implications for medicines access and for local industrial development within these East African countries. We show that in a context of poor access to reliable medicines, extensive reliance on private medicines purchase, and increasing globalisation of procurement systems, domestic linkages between health and industrial sectors have been weakened, especially in Tanzania. We argue in consequence for a more developmental perspective on health sector procurement design, including closer policy attention to strengthening vertical and horizontal relational working within local health-industry value chains, in the interests of both wider access to treatment and improved industrial development in Africa.

Suggested Citation

  • Mackintosh, Maureen & Tibandebage, Paula & Karimi Njeru, Mercy & Kariuki Kungu, Joan & Israel, Caroline & Mujinja, Phares G.M., 2018. "Rethinking health sector procurement as developmental linkages in East Africa," Social Science & Medicine, Elsevier, vol. 200(C), pages 182-189.
  • Handle: RePEc:eee:socmed:v:200:y:2018:i:c:p:182-189
    DOI: 10.1016/j.socscimed.2018.01.008
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S027795361830008X
    Download Restriction: Full text for ScienceDirect subscribers only

    File URL: https://libkey.io/10.1016/j.socscimed.2018.01.008?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Sudip Chaudhuri & Maureen Mackintosh & Phares G M Mujinja, 2010. "Indian Generics Producers, Access to Essential Medicines and Local Production in Africa: An Argument with Reference to Tanzania," The European Journal of Development Research, Palgrave Macmillan;European Association of Development Research and Training Institutes (EADI), vol. 22(4), pages 451-468, September.
    2. Wang'Ombe, Joseph K. & Mwabu, Germano M., 1987. "Economics of essential drugs schemes: The perspectives of the developing countries," Social Science & Medicine, Elsevier, vol. 25(6), pages 625-630, January.
    3. Huff-Rousselle, Maggie, 2012. "The logical underpinnings and benefits of pooled pharmaceutical procurement: A pragmatic role for our public institutions?," Social Science & Medicine, Elsevier, vol. 75(9), pages 1572-1580.
    4. Kenneth C. Shadlen & Elize Massard da Fonseca, 2013. "Health Policy as Industrial Policy," Politics & Society, , vol. 41(4), pages 561-587, December.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Chebolu-Subramanian, Vijaya & Sundarraj, Rangaraja P., 2021. "Essential medicine shortages, procurement process and supplier response: A normative study across Indian states," Social Science & Medicine, Elsevier, vol. 278(C).
    2. Hamill, Heather & Hampshire, Kate & Mariwah, Simon & Amoako-Sakyi, Daniel & Kyei, Abigail & Castelli, Michele, 2019. "Managing uncertainty in medicine quality in Ghana: The cognitive and affective basis of trust in a high-risk, low-regulation context," Social Science & Medicine, Elsevier, vol. 234(C), pages 1-1.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Diogo Ferraz & Fernanda P. S. Falguera & Enzo B. Mariano & Dominik Hartmann, 2021. "Linking Economic Complexity, Diversification, and Industrial Policy with Sustainable Development: A Structured Literature Review," Sustainability, MDPI, vol. 13(3), pages 1-29, January.
    2. Ramani, Shyama V. & Urias, Eduardo, 2018. "When access to drugs meets catch-up: Insights from the use of CL threats to improve access to ARV drugs in Brazil," Research Policy, Elsevier, vol. 47(8), pages 1538-1552.
    3. Dubois, Pierre & Lefouili, Yassine & Straub, Stéphane, 2021. "Pooled procurement of drugs in low and middle income countries," European Economic Review, Elsevier, vol. 132(C).
    4. Nazaré Rego & João Claro & Jorge Pinho de Sousa, 2014. "A hybrid approach for integrated healthcare cooperative purchasing and supply chain configuration," Health Care Management Science, Springer, vol. 17(4), pages 303-320, December.
    5. Dai, Rong & Watal, Jayashree, 2021. "Product patents and access to innovative medicines," Social Science & Medicine, Elsevier, vol. 291(C).
    6. Sabine Vogler & Eveli Bauer & Katharina Habimana, 2022. "Centralised Pharmaceutical Procurement: Learnings from Six European Countries," Applied Health Economics and Health Policy, Springer, vol. 20(5), pages 637-650, September.
    7. Rory Horner, 2022. "Global value chains, import orientation, and the state: South Africa’s pharmaceutical industry," Journal of International Business Policy, Palgrave Macmillan, vol. 5(1), pages 68-87, March.
    8. Sabine Vogler & Katharina Habimana & Manuel Alexander Haasis & Stefan Fischer, 2024. "Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally," Applied Health Economics and Health Policy, Springer, vol. 22(5), pages 629-652, September.
    9. Tamara Hafner & David Popp, 2011. "China and India as Suppliers of Affordable Medicines to Developing Countries," NBER Working Papers 17249, National Bureau of Economic Research, Inc.
    10. Bjerke, Lise, 2022. "Antibiotic geographies and access to medicines: Tracing the role of India's pharmaceutical industry in global trade," Social Science & Medicine, Elsevier, vol. 312(C).
    11. Prof. Emmanuel Awuor & Patrick Amponsah, 2023. "Local Manufacture of Pharmaceutical Commodities in Sub- Saharan Africa: An Empirical Literature Review," International Journal of Research and Innovation in Social Science, International Journal of Research and Innovation in Social Science (IJRISS), vol. 7(5), pages 470-481, May.
    12. Mai Duong & Rebekah J Moles & Betty Chaar & Timothy F Chen & World Hospital Pharmacy Research Consortium (WHoPReC), 2015. "Essential Medicines in a High Income Country: Essential to Whom?," PLOS ONE, Public Library of Science, vol. 10(12), pages 1-14, December.
    13. Hamill, Heather & Hampshire, Kate & Mariwah, Simon & Amoako-Sakyi, Daniel & Kyei, Abigail & Castelli, Michele, 2019. "Managing uncertainty in medicine quality in Ghana: The cognitive and affective basis of trust in a high-risk, low-regulation context," Social Science & Medicine, Elsevier, vol. 234(C), pages 1-1.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:200:y:2018:i:c:p:182-189. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.